Peter G. Linde's most recent trade in Morphic Holding Inc was a trade of 10,378 Restricted Stock Unit (RSU done . Disclosure was reported to the exchange on Sept. 16, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Morphic Holding Inc | Peter G. Linde | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2021 | 10,378 | 0 | - | - | Restricted Stock Unit (RSU | |
| Morphic Holding Inc | Peter G. Linde | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2021 | 10,378 | 15,272 (0%) | 0% | - | Common Stock | |
| Morphic Holding Inc | Peter G. Linde | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 66.48 per share. | 16 Sep 2021 | 3,276 | 11,896 (0%) | 0% | 66.5 | 217,803 | Common Stock |
| Morphic Holding Inc | Peter G. Linde | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 67.00 per share. | 16 Sep 2021 | 624 | 11,272 (0%) | 0% | 67.0 | 41,805 | Common Stock |
| Morphic Holding Inc | Peter G. Linde | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.29 per share. | 16 Sep 2021 | 100 | 15,172 (0%) | 0% | 64.3 | 6,429 | Common Stock |